Sivik Global Healthcare LLC Purchases 100,000 Shares of Select Medical Holdings Corporation $SEM

Key Points

• Sivik Global Healthcare LLC increased its stake in Select Medical Holdings Corporation by 50%, acquiring an additional 100,000 shares to bring its total to 300,000 shares.
• Major institutional investors, including GAMMA Investing LLC, have significantly increased their holdings in Select Medical, indicating strong overall interest in the company.
• Research analysts have mixed opinions on Select Medical, with Bank of America lowering its price target while Royal Bank of Canada raised theirs, resulting in an average rating of "Moderate Buy" with a consensus price target of $19.40.

Sivik Global Healthcare LLC raised its position in shares of Select Medical Holdings Corporation (NYSE:SEM - Free Report) by 50.0% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 300,000 shares of the health services provider's stock after purchasing an additional 100,000 shares during the quarter. Select Medical accounts for approximately 1.2% of Sivik Global Healthcare LLC's holdings, making the stock its 22nd biggest position. Sivik Global Healthcare LLC owned about 0.23% of Select Medical worth $4,554,000 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in SEM. GAMMA Investing LLC lifted its position in shares of Select Medical by 5,201.1% during the 1st quarter. GAMMA Investing LLC now owns 108,567 shares of the health services provider's stock valued at $1,813,000 after buying an additional 106,519 shares in the last quarter. SG Americas Securities LLC lifted its position in shares of Select Medical by 151.0% during the 1st quarter. SG Americas Securities LLC now owns 37,684 shares of the health services provider's stock valued at $629,000 after buying an additional 22,671 shares in the last quarter. Handelsbanken Fonder AB lifted its position in shares of Select Medical by 31.5% during the 1st quarter. Handelsbanken Fonder AB now owns 30,911 shares of the health services provider's stock valued at $516,000 after buying an additional 7,400 shares in the last quarter. Vista Finance LLC lifted its position in shares of Select Medical by 7.0% during the 1st quarter. Vista Finance LLC now owns 10,969 shares of the health services provider's stock valued at $183,000 after buying an additional 716 shares in the last quarter. Finally, Ritholtz Wealth Management purchased a new position in shares of Select Medical during the 1st quarter valued at about $460,000. 89.48% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of research analysts have recently weighed in on SEM shares. Bank of America lowered their price objective on Select Medical from $18.00 to $15.00 and set a "buy" rating on the stock in a research report on Wednesday, September 10th. Weiss Ratings reissued a "sell (d+)" rating on shares of Select Medical in a report on Wednesday. UBS Group reissued a "neutral" rating and issued a $14.00 price target (down from $15.00) on shares of Select Medical in a report on Monday, August 4th. Finally, Royal Bank Of Canada boosted their price target on Select Medical from $16.00 to $20.00 and gave the stock an "outperform" rating in a report on Wednesday. Four equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, Select Medical currently has an average rating of "Moderate Buy" and a consensus price target of $19.40.

Select Medical Stock Down 2.5%

NYSE SEM opened at $13.30 on Friday. The stock has a market cap of $1.65 billion, a PE ratio of 12.55, a P/E/G ratio of 0.54 and a beta of 1.28. Select Medical Holdings Corporation has a 12 month low of $11.65 and a 12 month high of $40.98. The stock's 50 day moving average is $12.75 and its 200 day moving average is $14.47. The company has a current ratio of 1.15, a quick ratio of 1.15 and a debt-to-equity ratio of 0.92.

Select Medical (NYSE:SEM - Get Free Report) last issued its quarterly earnings data on Thursday, July 31st. The health services provider reported $0.32 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.28 by $0.04. The business had revenue of $1.34 billion for the quarter, compared to analysts' expectations of $1.35 billion. Select Medical had a return on equity of 8.87% and a net margin of 2.37%.The company's revenue for the quarter was up 4.5% on a year-over-year basis. During the same period in the prior year, the firm earned $0.60 EPS. Select Medical has set its FY 2025 guidance at 1.090-1.19 EPS. Research analysts predict that Select Medical Holdings Corporation will post 1.17 EPS for the current fiscal year.

Select Medical Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Thursday, August 28th. Stockholders of record on Wednesday, August 13th were issued a dividend of $0.0625 per share. This represents a $0.25 annualized dividend and a dividend yield of 1.9%. The ex-dividend date of this dividend was Wednesday, August 13th. Select Medical's dividend payout ratio is 23.58%.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.

Want to see what other hedge funds are holding SEM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Select Medical Holdings Corporation (NYSE:SEM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.